GlobeNewswire (Nov 14, 2012)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
GlobeNewswire (Sep 5, 2012)
-
GlobeNewswire (Aug 30, 2012)
-
GlobeNewswire (Aug 9, 2012)
-
GlobeNewswire (Aug 7, 2012)
-
NeurogesX's CEO Discusses Q2 2012 Results - Earnings Call TranscriptMon, Aug 6, 2012
-
GlobeNewswire (Aug 3, 2012)
-
GlobeNewswire (Aug 2, 2012)
-
GlobeNewswire (Jul 27, 2012)
-
GlobeNewswire (Jul 24, 2012)
-
GlobeNewswire (Jul 16, 2012)
-
GlobeNewswire (Jun 29, 2012)
-
GlobeNewswire (Jun 19, 2012)
-
GlobeNewswire (Jun 18, 2012)
-
GlobeNewswire (May 3, 2012)
-
GlobeNewswire (Apr 27, 2012)
-
GlobeNewswire (Apr 20, 2012)
-
GlobeNewswire (Apr 17, 2012)
To learn more about Seeking Alpha Pro, click here.
-
NeurogesX: Positive MomentumZacks Investment Research • Wed, Jun 10, 2009
-
NeurogesX: Qutenza Nearing Approval, Looks PromisingZacks Investment Research • Mon, May 11, 2009
-
NeurogesX Awaiting Dual Regulatory DecisionsMike Havrilla • Sun, May 10, 2009
-
NeurogesX Fundamentals ImproveZacks Investment Research • Tue, Mar 24, 2009
-
Now's The Time To Hop Aboard NeurogesXBrett Scott • Wed, Sep 5, 2007
-
Three Reasons to Be Optimstic on NeurogesXBrett Scott • Thu, Aug 16, 2007
-
Neurogesx: A Speculative Biotech InvestmentBrett Scott • Tue, Jul 24, 2007
-
Broken IPO NeurogesX Names BioMarin Pharma CEO as New ChairmanRichard Shonfeld • Wed, May 30, 2007
-
Volume Talks Wednesday: A Bullish Biotech Breakout Option PlayOption Maestro • Thu, Mar 25, 2010
-
BioMed News Bytes: GeoVax, Cerus, Discovery Labs, NeurogesXMike Havrilla • Wed, Nov 18, 2009
-
FDA Calendar Updates: NeurogesX, ThoratecMike Havrilla • Thu, Aug 6, 2009
-
FDA Calendar Updates: Celgene, NeurogesX, RigelMike Havrilla • Fri, Jul 24, 2009
-
NeurogesX's CEO Discusses Q2 2012 Results - Earnings Call TranscriptMon, Aug 6, 2012
-
NeurogesX Inc. Q1 2010 Earnings Call TranscriptTue, May 11, 2010
-
NeurogesX Inc. Q4 2007 Earnings Call TranscriptWed, Mar 26, 2008
-
GlobeNewswire (Nov 14, 2012)
-
GlobeNewswire (Sep 5, 2012)
-
GlobeNewswire (Aug 30, 2012)
-
GlobeNewswire (Aug 9, 2012)
-
GlobeNewswire (Aug 7, 2012)
-
GlobeNewswire (Aug 3, 2012)
-
GlobeNewswire (Aug 2, 2012)
-
GlobeNewswire (Jul 27, 2012)
-
GlobeNewswire (Jul 24, 2012)
-
GlobeNewswire (Jul 16, 2012)
-
GlobeNewswire (Jun 29, 2012)
-
GlobeNewswire (Jun 19, 2012)
-
GlobeNewswire (Jun 18, 2012)
-
GlobeNewswire (May 3, 2012)
-
GlobeNewswire (Apr 27, 2012)
-
GlobeNewswire (Apr 20, 2012)
-
GlobeNewswire (Apr 17, 2012)
-
GlobeNewswire (Apr 11, 2012)
-
GlobeNewswire (Jan 3, 2012)
NGSX.OB vs. ETF Alternatives
Company Description
We are a biopharmaceutical company focused on developing and commercializing novel pain management therapies. We are assembling a portfolio of pain management product candidates based on known chemical entities to develop innovative new therapies which we believe may offer substantial advantages... More